Dyskeratosis congenitaRÖTH, Alexander; BAERLOCHER, Gabriela M.British journal of haematology. 2008, Vol 141, Num 4, pp 412-412, issn 0007-1048, 1 p.Article

Telomere loss, senescence, and genetic instability in CD4⁺T lymphocytes overexpressing hTERTRÖTH, Alexander; BAERLOCHER, Gabriela M; SCHERTZER, Mike et al.Blood. 2005, Vol 106, Num 1, pp 43-50, issn 0006-4971, 8 p.Article

Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxisHEIZMANN, Marc; BAERLOCHER, Gabriela M; STEINMANN, Felix et al.Thrombosis research. 2002, Vol 106, Num 4-5, pp 179-181, issn 0049-3848, 3 p.Article

TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis CongenitaSAVAGE, Sharon A; GIRI, Neelam; BAERLOCHER, Gabriela M et al.American journal of human genetics. 2008, Vol 82, Num 2, pp 501-509, issn 0002-9297, 9 p.Article

Functional characterization of telomerase RNA variants found in patients with hematologic disordersLY, Hinh; CALADO, Rodrigo T; ALLARD, Paulette et al.Blood. 2005, Vol 105, Num 6, pp 2332-2339, issn 0006-4971, 8 p.Article

Telomeres and prognosis in patients with chronic lymphocytic leukaemiaSELLMANN, Ludger; DE BEER, Dirk; BAERLOCHER, Gabriela M et al.International journal of hematology. 2011, Vol 93, Num 1, pp 74-82, issn 0925-5710, 9 p.Article

Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IVHEHLMANN, Rüdiger; MÜLLER, Martin C; SCHNITTGER, Susanne et al.Journal of clinical oncology. 2014, Vol 32, Num 5, pp 415-423, issn 0732-183X, 9 p.Article

Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sexBAERLOCHER, Gabriela M; ROVO, Alicia; MÜLLER, Astrid et al.Blood. 2009, Vol 114, Num 1, pp 219-222, issn 0006-4971, 4 p.Article

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNAFOGARTY, Patrick F; YAMAGUCHI, Hiroki; WIESTNER, Adrian et al.Lancet (British edition). 2003, Vol 362, Num 9396, pp 1628-1630, issn 0140-6736, 3 p.Article

Telomere length is associated with disease severity and declines with age in dyskeratosis congenitaALTER, Blanche P; ROSENBERG, Philip S; GIRI, Neelam et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 353-359, issn 0390-6078, 7 p.Article

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IVFABARIUS, Alice; LEITNER, Armin; JUNG-MUNKWITZ, Susanne et al.Blood. 2011, Vol 118, Num 26, pp 6760-6768, issn 0006-4971, 9 p.Article

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenitaALTER, Blanche P; BAERLOCHER, Gabriela M; SAVAGE, Sharon A et al.Blood. 2007, Vol 110, Num 5, pp 1439-1447, issn 0006-4971, 9 p.Article

Significantly shorter telomeres in T-cells of patients with ZAP-70⁺/CD38⁺ chronic lymphocytic leukaemiaROTH, Alexander; DE BEER, Dirk; NÜCKEL, Holger et al.British journal of haematology. 2008, Vol 143, Num 3, pp 383-386, issn 0007-1048, 4 p.Article

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemiaYAMAGUCHI, Hiroki; CALADO, Rodrigo T; LY, Hinh et al.The New England journal of medicine. 2005, Vol 352, Num 14, pp 1413-1424, issn 0028-4793, 12 p.Article